Birth control<unk>  is used primarily in birth control pills in combination with ethinylestradiol under the brand name Valette. It is also available in a quadriphasic birth control pill combined with estradiol valerate, marketed as Natazia in the United States and Qlaira in some European countries and Russia. Endometriosis<unk>  is approved as a standalone medication under the brand names Visanne and Dinagest in various places such as Europe, Australia, Japan, Singapore, and Malaysia for the treatment of endometriosis. It has been found to be equally effective as gonadotropin-releasing hormone agonists (GnRH agonists), such as leuprorelin, in the treatment of endometriosis. Heavy periods Birth control pills containing<unk>  and estradiol valerate are approved in the United States for the treatment of menorrhagia (heavy menstrual bleeding). Menopausal symptoms<unk>  is used in combination with estradiol valerate in the treatment of menopausal symptoms in certain countries such as Germany and the Netherlands. Available forms<unk>  is available both alone and in combination with estrogens. The following formulations are available: *<unk>  1 mg oral tablets (Dinagest) and 2 mg oral tablets (Valette) (not available in U.S.) – indicated for endometriosis *<unk>  2 mg and estradiol valerate 3 mg oral tablets (Natazia) (U.S.) – indicated for contraception and menorrhagia * 2 dark yellow tablets each containing 3 mg estradiol valerate * 5 medium red tablets each containing 2 mg estradiol valerate and 2 mg<unk>  * 17 light yellow tablets each containing 2 mg estradiol valerate and 3 mg<unk>  * 2 dark red tablets each containing 1 mg estradiol valerate * 2 white tablets (inert) *<unk>  2 to 3 mg and estradiol valerate 1 to 3 mg oral tablets (Qlaira) (not available in U.S.) – indicated for contraception * Each dark yellow active tablet contains 3 mg estradiol valerate * Each medium red active tablet contains 2 mg estradiol valerate and 2 mg<unk>  * Each light yellow active tablet contains 2 mg estradiol valerate and 3 mg<unk>  * Each dark red active tablet contains 1 mg estradiol valerate *<unk>  2 mg and ethinylestradiol 30 µg oral tablets (Valette) – indicated for contraception *<unk>  2 mg and estradiol valerate 1 or 2 mg oral tablets (various) – indicated for menopausal hormone therapy The availability of these formulations differs by country (see Availability).
Dienogest
Nafarelin
Estropipate
Degarelix
Protollin
Gestodene
Tesamorelin
Macimorelin